Media Pack
News

Current Edition

Volume 6 Issue 3

Upcoming Events

Advertisement

 
 
Volume 5 Issue 3

Automated Sterile Manufacturing and Packaging Solutions Aiding Speed to Patient

The biologic market has grown expediently over the past few years, driven not only by the pandemic but also by the increasing demand for innovative therapies, the con...
12 October 2022 Volume 5 Issue 3 automated | biologic
Continue Reading →
news

Bluebird’s CFO resigns as cash woes raise doubts about its future

Dive Brief: Bluebird bio's chief financial officer Gina Consylman will resign amid growing concerns the company needs to raise additional money to survive more tha...
14 March 2022 news Bluebird | financial
Continue Reading →
news

Pfizer’s big bet on mRNA, Biogen ‘proven wrong’ on Aduhelm price and the next cell therapies

Biotechnology stocks ended the first day of the J.P. Morgan Healthcare Conference in the green, but only barely. By Monday afternoon, a closely followed index of the ...
14 January 2022 news Alzheimer | cell
Continue Reading →
news

Takeda reels in a cell therapy research partner with ‘build-to-buy’ deal

Takeda, which has made cell and gene therapy a research focus, is turning to partnerships and acquisitions to help fill out its pipeline. In addition to the GammaDelt...
29 October 2021 news allogeneic | cell
Continue Reading →
news

Gene Therapies That Could Transform Diseases Get Easier FDA Path

New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by the Food and Drug Administr...
25 May 2018 news diseases | easier
Continue Reading →
 
 
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2023, All Rights Reserved – Powered by Teksyte